Paper Details

  1. Home
  2. Paper Details

Acyclovir in first attacks of genital herpes and prevention of recurrences.

Author: AdlerM W, FahertyA, FiddianA P, MindelA, SutherlandS, WellerI V

Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

A study of 60 patients with first-time genital herpes found that oral acyclovir for 42 days was more effective in delaying the first recurrence compared to a 5-day course of acyclovir followed by placebo.
Paper Details　
Original Abstract of the Article :
Sixty women patients experiencing a first attack of genital herpes were randomly treated with either oral acyclovir for 42 days or oral acyclovir for five days followed by placebo for 37 days. The median time to the first recurrence in patients receiving acyclovir for 42 days was 66.5 days compared ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1136/sti.62.1.28

データ提供：米国国立医学図書館（NLM）

Acyclovir: A Powerful Weapon Against Genital Herpes

This research investigates the efficacy of acyclovir, an antiviral medication, in treating first attacks of genital herpes and preventing recurrences. It's like a scientist studying a new type of shield, seeking to protect individuals from a viral invasion. The researchers, like warriors battling a formidable foe, conducted a randomized controlled trial to compare the effects of acyclovir given for a longer duration versus a shorter duration. They found that acyclovir given for 42 days significantly reduced the time to the first recurrence compared to acyclovir given for only 5 days.

A Shield Against Recurrences: Managing Genital Herpes

This study highlights the effectiveness of acyclovir in managing genital herpes. It's like a fortress, offering protection from a relentless enemy. Acyclovir can help prevent the painful symptoms of herpes outbreaks, reducing the frequency and severity of recurrences.

Living with Herpes: A Journey of Understanding and Support

This research underscores the importance of early diagnosis and treatment for genital herpes. It's like a desert traveler seeking guidance and support as they navigate a challenging journey. By understanding the disease and adhering to recommended treatment strategies, individuals can manage their condition and live fulfilling lives.

Dr. Camel's Conclusion

This study underscores the effectiveness of acyclovir in treating genital herpes and preventing recurrences. It's a journey of progress, seeking to improve the lives of those affected by this common and often misunderstood condition. Acyclovir offers hope and empowers individuals to manage their condition and live fulfilling lives.

Date :
  1. Date Completed 1986-04-15
  2. Date Revised 2019-05-03
Further Info :

Pubmed ID

3512419

DOI: Digital Object Identifier

10.1136/sti.62.1.28

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.